These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 3998751

  • 1. Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease.
    Perry EK, Curtis M, Dick DJ, Candy JM, Atack JR, Bloxham CA, Blessed G, Fairbairn A, Tomlinson BE, Perry RH.
    J Neurol Neurosurg Psychiatry; 1985 May; 48(5):413-21. PubMed ID: 3998751
    [Abstract] [Full Text] [Related]

  • 2. Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases.
    Candy JM, Perry RH, Perry EK, Irving D, Blessed G, Fairbairn AF, Tomlinson BE.
    J Neurol Sci; 1983 May; 59(2):277-89. PubMed ID: 6854353
    [Abstract] [Full Text] [Related]

  • 3. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.
    Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH.
    Br Med J; 1978 Nov 25; 2(6150):1457-9. PubMed ID: 719462
    [Abstract] [Full Text] [Related]

  • 4. [Dementia and Parkinson's disease: biochemical and anatomo-clinical correlation].
    Dubois B, Hauw JJ, Ruberg M, Serdaru M, Javoy-Agid F, Agid Y.
    Rev Neurol (Paris); 1985 Nov 25; 141(3):184-93. PubMed ID: 4001706
    [Abstract] [Full Text] [Related]

  • 5. The current status of the cortical cholinergic system in Alzheimer's disease and Parkinson's disease.
    Candy JM, Perry EK, Perry RH, Court JA, Oakley AE, Edwardson JA.
    Prog Brain Res; 1986 Nov 25; 70():105-32. PubMed ID: 3554348
    [No Abstract] [Full Text] [Related]

  • 6. The substantia innominata in Alzheimer's disease: an histochemical and biochemical study of cholinergic marker enzymes.
    Rossor MN, Svendsen C, Hunt SP, Mountjoy CQ, Roth M, Iversen LL.
    Neurosci Lett; 1982 Feb 12; 28(2):217-22. PubMed ID: 7070710
    [Abstract] [Full Text] [Related]

  • 7. Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer's disease.
    Perry RH, Candy JM, Perry EK, Irving D, Blessed G, Fairbairn AF, Tomlinson BE.
    Neurosci Lett; 1982 Dec 13; 33(3):311-5. PubMed ID: 7162693
    [Abstract] [Full Text] [Related]

  • 8. Cholinergic enzymes in neocortex, hippocampus and basal forebrain of non-neurological and senile dementia of Alzheimer-type patients.
    Henke H, Lang W.
    Brain Res; 1983 May 16; 267(2):281-91. PubMed ID: 6871677
    [Abstract] [Full Text] [Related]

  • 9. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease.
    Perry EK, Haroutunian V, Davis KL, Levy R, Lantos P, Eagger S, Honavar M, Dean A, Griffiths M, McKeith IG.
    Neuroreport; 1994 Mar 21; 5(7):747-9. PubMed ID: 8018843
    [Abstract] [Full Text] [Related]

  • 10. Galanin-like immunoreactivity is unchanged in Alzheimer's disease and Parkinson's disease dementia cerebral cortex.
    Beal MF, Clevens RA, Chattha GK, MacGarvey UM, Mazurek MF, Gabriel SM.
    J Neurochem; 1988 Dec 21; 51(6):1935-41. PubMed ID: 2460590
    [Abstract] [Full Text] [Related]

  • 11. Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities.
    Wilcock GK, Esiri MM, Bowen DM, Smith CC.
    J Neurol Sci; 1982 Dec 21; 57(2-3):407-17. PubMed ID: 7161627
    [Abstract] [Full Text] [Related]

  • 12. Choline acetyltransferase and acetylcholinesterase abnormalities in senile dementia: importance of biochemical measurements in human post-mortem brain specimens.
    Sorbi S, Antuono P, Amaducci L.
    Ital J Neurol Sci; 1980 Mar 21; 1(2):75-83. PubMed ID: 7040296
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cortical neuropathological and neurochemical substrates of Alzheimer's and Parkinson's diseases.
    Perry RH, Perry EK, Smith CJ, Xuereb JH, Irving D, Whitford CA, Candy JM, Cross AJ.
    J Neural Transm Suppl; 1987 Mar 21; 24():131-6. PubMed ID: 2824687
    [Abstract] [Full Text] [Related]

  • 16. Cortical serotonin-S2 receptor binding abnormalities in patients with Alzheimer's disease: comparisons with Parkinson's disease.
    Perry EK, Perry RH, Candy JM, Fairbairn AF, Blessed G, Dick DJ, Tomlinson BE.
    Neurosci Lett; 1984 Oct 26; 51(3):353-7. PubMed ID: 6521962
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intralaminar neurochemical distributions in human midtemporal cortex: comparison between Alzheimer's disease and the normal.
    Perry EK, Atack JR, Perry RH, Hardy JA, Dodd PR, Edwardson JA, Blessed G, Tomlinson BE, Fairbairn AF.
    J Neurochem; 1984 May 26; 42(5):1402-10. PubMed ID: 6142924
    [Abstract] [Full Text] [Related]

  • 19. Cortical somatostatin-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.
    Davies P, Terry RD.
    Neurobiol Aging; 1981 May 26; 2(1):9-14. PubMed ID: 6115327
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.